Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #442
- Final score
- 52.34
- Years on list
- 6
↘ Down 105 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 105 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 215 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 293 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | PRGO | WST | ALNY |
|---|---|---|---|
| Climate Change | 58.7 | 55.0 | 48.5 |
| Employee Relations | 40.8 | 46.0 | 63.5 |
| Environment | 55.8 | 65.7 | 61.1 |
| Stakeholders & Society | 50.9 | 54.4 | 48.7 |
| Human Rights | 74.6 | 40.3 | 31.7 |
| Governance | 37.2 | 44.7 | 42.1 |
| Performance Rating | 40.1 | 53.0 | 64.7 |